South Asian diabetic macular oedema treated with ranibizumab (ADMOR)—real-life experience
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Arts and Humanities,Ophthalmology,Sensory Systems
Link
http://www.nature.com/articles/eye2015209.pdf
Reference19 articles.
1. Sivaprasad S, Gupta B, Gulliford MC, Dodhia H, Mann S, Nagi D et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One 2012; 7: e32182.
2. Massin P, Bandello F, Garweg JG, Hansen L, Larsen M, Mitchell P et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study). Diabetes Care 2010; 33: 2399–2405.
3. Nguyen QD, Shah SM, Khwaja AA, Channa R, Sepah YJ, Sophie R et al. Two-year outcomes of the ranibizumab for edema of the macula in Diabetes (READ—2) Study. Ophthalmology 2010; 117: 2146–2151.
4. Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L et al. Ranibizumab for diabetic macular edema. Results from 2 Phase III Randomized trials: RISE and RIDE. Ophthalmology 2012; 119: 789–801.
5. Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from two phase III Trials. RISE and RIDE. Ophthalmology 2013; 120: 2013–2022.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data;European Journal of Ophthalmology;2024-03-11
2. Evaluating initial responses to brolucizumab in patients undergoing conventional anti-VEGF therapy for diabetic macular edema: a retrospective, single-center, observational study;Scientific Reports;2023-07-05
3. Evaluating initial responses to brolucizumab in patients undergoing conventional anti- VEGF therapy for diabetic macular edema: A retrospective, single-center, observational study;2023-05-30
4. A rapid review of evidence relating to service use, experiences, and support needs of adults from minority ethnic communities along the eyecare pathway in the United Kingdom;Frontiers in Public Health;2023-02-28
5. Factors affecting central macular thickness of diabetic macular oedema patients after an induction treatment of intravitreal ranibizumab;Tropical Medicine & International Health;2023-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3